Free Trial

Bio-Rad Laboratories (BIO) News Today

Bio-Rad Laboratories logo
Bio-Rad Laboratories, Inc. (BIO): A Bull Case Theory
RBC Capital Sticks to Its Buy Rating for QuidelOrtho (QDEL)
Palantir and Dell are set to join the S&P 500 Monday
RBC Capital Remains a Buy on Thermo Fisher (TMO)
Dell, Palantir to join S&P 500 on September 23
Palantir stock surges on huge S&P 500 decision
Biodesix to Present at Two Investor Conferences in September
BIO Aug 2024 240.000 call
BIO Sep 2024 350.000 call
Bio-Rad Reports Second-Quarter 2024 Financial Results
Q1 2024 OncoCyte Corp Earnings Call
Bio-Rad: Q1 Earnings Snapshot
Here's what to expect from Bio-Rad Laboratories B's earnings
Bio-Rad Laboratories earnings: here's what Wall Street expects
Get Bio-Rad Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter.

Forced out of retirement by these trades (Ad)

You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changed

Make sure to check out Gamma Pockets HERE while it’s still widely available 

BIO Media Mentions By Week

BIO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BIO
News Sentiment

0.00

0.60

Average
Medical
News Sentiment

BIO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BIO Articles
This Week

0

1

BIO Articles
Average Week

Get Bio-Rad Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (CNSX:BIO) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners